Da Hee Han, PharmD, Author at Hematology Advisor
Skip to navigation Skip to main content

Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

Bleeding Disorders

Esperoct Approval Provides New Treatment Option for Hemophilia A

By
Publish Date

Novo Nordisk announced that the Food and Drug Administration (FDA) has approved Esperoct (turoctocog alfa pegol, N8-GP) for the treatment of patients with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment and control of bleeding episodes and perioperative management of bleeding.

Next post in Bleeding Disorders